Targeting protein modification: a new direction for immunotherapy of pancreatic cancer

被引：1
作者：
Ge, Xinyu [1 ]
Zhang, Ke [2 ]
Zhu, Jie [1 ]
Chen, Yuan [1 ]
Wang, Zhengwang [1 ]
Wang, Peng [1 ]
Xu, Peng [1 ]
Yao, Jie [1 ]
机构：
[1] Yangzhou Univ, Northern Jiangsu Peoples Hosp, Dept Hepatobiliary & Pancreat Surg, Yangzhou 225000, Jiangsu, Peoples R China
[2] Dalian Med Univ, Yangzhou Sch Clin Med, Yangzhou 225000, Jiangsu, Peoples R China
来源：
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES | 2025年 / 21卷 / 01期
基金：
中国国家自然科学基金;
关键词：
Post-translational modifications; Immunotherapy; Targeted therapy; Immune escape; Pancreatic cancer; PD-L1; EXPRESSION; AUGMENTS IMMUNOTHERAPY; ACTIVATION; INHIBITION; PHOSPHORYLATION; GLYCOSYLATION; PATHWAY; GROWTH; CELLS; SUMO;
D O I：
10.7150/ijbs.101861
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Post-translational modifications (PTMs) alter protein conformation by covalently attaching functional groups to substrates, influencing their biological activity, mechanisms of action, and functional performance. PTMs and their interactions are essential to many critical signal transduction processes, including tumor transformation, cancer progression, and metastasis in pancreatic cancer. Additionally, advancements in tumor immunotherapy indicate that PTMs are essential in immune cell activation, transport, and energy metabolism. This study aimed to investigate the effects of different PTMs on immunotherapy for pancreatic cancer, providing new perspectives and suggesting directions for future research.
引用
收藏
页码：63 / 74
页数：12
相关论文
共 167 条
  • [1] Selective inhibition of the p38 alternative activation pathway in infiltrating T cells inhibits pancreatic cancer progression
    Alam, Muhammad S.
    Gaida, Matthias M.
    Bergmann, Frank
    Lasitschka, Felix
    Giese, Thomas
    Giese, Nathalia A.
    Hackert, Thilo
    Hinz, Ulf
    Hussain, S. Perwez
    Kozlov, Serguei V.
    Ashwell, Jonathan D.
    [J]. NATURE MEDICINE, 2015, 21 (11) : 1337 - 1343
  • [2] Counter-regulation of T cell effector function by differentially activated p38
    Alam, Muhammad S.
    Gaida, Matthias M.
    Ogawa, Youichi
    Kolios, Antonios G. A.
    Lasitschka, Felix
    Ashwell, Jonathan D.
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2014, 211 (06) : 1257 - 1270
  • [3] ACETYLATION + METHYLATION OF HISTONES + THEIR POSSIBLE ROLE IN REGULATION OF RNA SYNTHESIS
    ALLFREY, VG
    FAULKNER, R
    MIRSKY, AE
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1964, 51 (05) : 786 - +
  • [4] New nomenclature for chromatin-modifying enzymes
    Allis, C. David
    Berger, Shelley L.
    Cote, Jacques
    Dent, Sharon
    Jenuwien, Thomas
    Kouzarides, Tony
    Pillus, Lorraine
    Reinberg, Danny
    Shi, Yang
    Shiekhattar, Ramin
    Shilatifard, Ali
    Workman, Jerry
    Zhang, Yi
    [J]. CELL, 2007, 131 (04) : 633 - 636
  • [5] Obstacles Posed by the Tumor Microenvironment to T cell Activity: A Case for Synergistic Therapies
    Anderson, Kristin G.
    Stromnes, Ingunn M.
    Greenberg, Philip D.
    [J]. CANCER CELL, 2017, 31 (03) : 311 - 325
  • [6] Engineered in vitro tumor models for cell-based immunotherapy
    Ando, Yuta
    Mariano, Chelsea
    Shen, Keyue
    [J]. ACTA BIOMATERIALIA, 2021, 132 : 345 - 359
  • [7] The USP22 promotes the growth of cancer cells through the DYRK1A in pancreatic ductal adenocarcinoma
    Bai, Zhile
    Du, Yang
    Cong, Lin
    Cheng, Yong
    [J]. GENE, 2020, 758
  • [8] Toward a repositioning of the antibacterial drug nifuroxazide for cancer treatment
    Bailly, Christian
    [J]. DRUG DISCOVERY TODAY, 2019, 24 (09) : 1930 - 1936
  • [9] Broadening the Impact of Immunotherapy to Pancreatic Cancer: Challenges and Opportunities
    Balachandran, Vinod P.
    Beatty, Gregory L.
    Dougan, Stephanie K.
    [J]. GASTROENTEROLOGY, 2019, 156 (07) : 2056 - 2072
  • [10] Aiming for the Sweet Spot: Glyco-Immune Checkpoints and γδ T Cells in Targeted Immunotherapy
    Bartish, Margarita
    del Rincon, Sonia V.
    Rudd, Christopher E.
    Saragovi, H. Uri
    [J]. FRONTIERS IN IMMUNOLOGY, 2020, 11
12345678910